{"id":"nct:NCT00553124","kind":"trial","title":"Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer","authors":["University Hospital Birmingham"],"author_count":1,"year":2007,"published":"2007-11-05","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT00553124","source_url":"https://clinicaltrials.gov/study/NCT00553124","archive_url":"https://space-kitty.com/papers/nct:NCT00553124","updated":"2014-01-10","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"RATIONALE: Studying different factors that effect patients with newly diagnosed bladder cancer may help doctors learn more about the disease, improve the ability to plan cancer treatment, and help patients live more comfortably. PURPOSE: This clinical trial is studying different factors affecting patients with newly diagnosed bladder cancer.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Bladder Cancer"],"details":{"acronym":null,"status":"UNKNOWN","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":3400,"sponsor":"University Hospital Birmingham","conditions":["Bladder Cancer"],"interventions":["DRUG: selenium","DRUG: vitamin E","PROCEDURE: biopsy","PROCEDURE: chemoprevention","PROCEDURE: cryopreservation","PROCEDURE: cytology specimen collection procedure","PROCEDURE: diagnostic procedure","PROCEDURE: gene expression analysis","PROCEDURE: immunohistochemistry staining method","PROCEDURE: laboratory biomarker analysis"],"start_date":"2005-12-01","start_date_type":null,"primary_completion_date":null,"has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"gene-cell-therapy","name":"Gene & Cell Therapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}